See also this year's filing and all EDGAR filings for this company.
PDF Report 0001017491_2022_Seelos_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001017491, Seelos Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 83,461,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 39,000 |
| 4 | LiabilitiesCurrent | 8,287,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 17,890,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,093,169 |
| 9 | ResearchAndDevelopmentExpense | 28,436,336 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -3,389,843 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 83,500,000 |
| 1 | Liabilities | 26,177,000 |
| 2 | Expenses | 46,529,505 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 57,323,000 |
| 5 | NetIncome | -49,919,348 |
| 6 | ComprehensiveNetIncome | -49,919,348 |
| 7 | BaseVar | 79,798,174 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.37 |
| 9 | EconomicCapitalRatio | 2.58 |